- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 00:01 | XFRA NEW INSTRUMENTS AVAILABLE ON 22.10.2026 | 101 | Xetra Newsboard | The following instruments on XETRA do have their first trading 22.10.2026 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 22.10.2026
Aktien
1 NZLODE0003S3 Lodestone Energy Ltd.
2... ► Artikel lesen | |
| 13.10. | IMRICOR MEDICAL SYSTEMS INC.: Notification of cessation of securities - IMR | 4 | ASX | ||
| 12.10. | IMRICOR MEDICAL SYSTEMS INC.: Notification regarding unquoted securities - IMR | 2 | ASX | ||
| 08.10. | IMRICOR MEDICAL SYSTEMS INC.: FDA Completes Review of Third PMA Module | - | ASX | ||
| 18.09. | IMRICOR MEDICAL SYSTEMS INC.: Cleansing Notice | 1 | ASX | ||
| 18.09. | IMRICOR MEDICAL SYSTEMS INC.: Application for quotation of securities - IMR | 1 | ASX | ||
| 03.09. | IMRICOR MEDICAL SYSTEMS INC.: FDA Accepts Imricor PMA Manufacturing Module | 3 | ASX | ||
| 28.08. | Imricor Medical Systems: Philips und Imricor bringen eine Lösung für ein MR-Labor für kardiale Interventionen auf den Markt und bauen damit ihre langjährige Zusammenarbeit aus | 540 | Business Wire | Royal Philips (NYSE: PHG, AEX: PHIA), ein weltweit führendes Unternehmen im Bereich der Gesundheitstechnologie, und Imricor Medical Systems (ASX: IMR), ein Pionier und weltweit führender Entwickler... ► Artikel lesen | |
| IMRICOR MEDICAL SYSTEMS INC Aktie jetzt für 0€ handeln | |||||
| 28.08. | Imricor Med and Philips launch commercial iMR lab solution | 2 | The Market Online Australia | ||
| 28.08. | Imricor Medical Systems and Philips launch MR-guided cardiac interventions lab | 2 | The Motley Fool Australia | ||
| 28.08. | IMRICOR MEDICAL SYSTEMS INC.: Imricor and Philips Launch Commercial iMR Lab Solution | - | ASX | ||
| 27.08. | Imricor Medical Systems: Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration | 574 | Business Wire | Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and world-leading developer of MR-compatible products for interventional... ► Artikel lesen | |
| 27.08. | Philips, Imricor launch MR-guided cardiac intervention technology | 2 | MassDevice | ||
| 27.08. | Philips und Imricor stellen Lösung für MRT-gesteuerte kardiologische Eingriffe vor | 4 | Investing.com Deutsch | ||
| 27.08. | Royal Philips: Philips and Imricor launch cardiac interventional MR lab solution, expanding longstanding collaboration | 1.548 | GlobeNewswire (Europe) | August 27, 2026 The solution combines Philips' high-performance 1.5T MRI platform and advanced interventional workflow capabilities with Imricor's exclusive portfolio of systems and consumables for... ► Artikel lesen | |
| 10.08. | Imricor 1H 2026 slides: FDA wins mount as U.S. launch begins | 2 | Investing.com | ||
| 10.08. | Imricor 1H 2026 slides: FDA clearances advance despite tiny revenue | 1 | Investing.com | ||
| 10.08. | IMRICOR MEDICAL SYSTEMS INC.: Imricor U.S. Commercial Momentum Accelerates | - | ASX | ||
| 10.08. | IMRICOR MEDICAL SYSTEMS INC.: 2026 Q2 Form 10-Q | 2 | ASX | ||
| 10.08. | IMRICOR MEDICAL SYSTEMS INC.: 1H 2026 Investor Presentation | 1 | ASX |
1 2 3 4 Weiter >>
67 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 62,36 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| HEARTFLOW | 55,82 | 0,00 % | Piper Sandler raises HeartFlow stock price target on competitive moat | ||
| AVEANNA HEALTHCARE | 12,990 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 12,330 | 0,00 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| CONCENTRA GROUP | 39,110 | +0,03 % | Stephens initiates Concentra stock with overweight on health model | ||
| GERRESHEIMER | 32,080 | 0,00 % | EQS-PVR: Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Gerresheimer AG
Gerresheimer AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
15.10.2026 / 13:52 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| BETA BIONICS | 18,390 | -0,05 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,445 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Expands Medicare Advantage Plan to Nye County for 2027 | ||
| BILLIONTOONE | 104,58 | -0,09 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| GENEDX | 68,95 | +0,01 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| STARLING ONCOLOGY INSTITUTE | 6,830 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| PROGYNY | 28,440 | 0,00 % | Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report | ||
| PRIVIA HEALTH GROUP | 22,465 | -0,02 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen | |
| KESTRA MEDICAL TECHNOLOGIES | 27,260 | 0,00 % | Kestra Medical Technologies: Evercore-Einstufung treibt Aktie vorbörslich an | ||
| MIMEDX | 3,735 | -0,13 % | Sanara MedTech/MiMedx deal spread widens on FTC second request |
Das Unternehmen IMRICOR MEDICAL SYSTEMS INC CDIS kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,805 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IMRICOR MEDICAL SYSTEMS INC CDIS finden Sie auf Wallstreet Online.